Adjuvant anabolic agents: a case report on the successful use of oxandrolone in an HIV-positive patient with chronic stasis ulceration.
Chronic venous stasis ulcers and HIV represent 2 prevalent disease processes in the urban wound care setting. To best serve our patients, it is important that the wound care team carefully consider the impact of comorbidities and consider use of nutritional interventions. In this article we report the use of the anabolic agent oxandrolone to successfully treat an HIV-positive man with stasis ulceration.
Cioroiu
M
M
Cabrini Wound Care Center, New York, New York, USA.
Hanan
S H
SH
D045930:Anabolic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002908:Chronic Disease; D006679:HIV Seropositivity / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010074:Oxandrolone / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome; D014647:Varicose Ulcer / Q000188:drug therapy* / Q000473:pathology / Q000821:virology*; D014945:Wound Healing / Q000187:drug effects
D045930:Anabolic Agents; D010074:Oxandrolone